We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

152 hedge funds and large institutions have $2.24B invested in Heron Therapeutics in 2018 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 54 increasing their positions, 39 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

147% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 19

79% more capital invested

Capital invested by funds: $1.25B → $2.24B (+$991M)

60% more funds holding in top 10

Funds holding in top 10: 5 → 8 (+3)

38% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 39

23% more funds holding

Funds holding: 124 → 152 (+28)

18.42% more ownership

Funds ownership: 107.15% → 125.57% (+18%)

10% more call options, than puts

Call options by funds: $39.4M | Put options by funds: $35.7M

Holders
152
Holders Change
+28
Holders Change %
+22.58%
% of All Funds
3.48%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.18%
New
47
Increased
54
Reduced
39
Closed
19
Calls
$39.4M
Puts
$35.7M
Net Calls
+$3.62M
Net Calls Change
-$7.32M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$49.3M
2
BBA
Baker Bros. Advisors
New York
+$44.6M
3
EAM
Eagle Asset Management
Florida
+$41.1M
4
ACH
ArrowMark Colorado Holdings
Colorado
+$34.7M
5
BM
Bridger Management
New York
+$29M

Top Sellers

1
CC
Carlson Capital
Texas
-$26.2M
2
Franklin Resources
Franklin Resources
California
-$26.2M
3
RCMNY
Rubric Capital Management (New York)
New York
-$15.6M
4
Citadel Advisors
Citadel Advisors
Florida
-$15M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$12.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$292M +$22.1M +975,248 +10%
TCM
2
Tang Capital Management
California
$239M +$4.13M +181,875 +2%
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$221M +$21.8M +959,488 +14%
Franklin Resources
4
Franklin Resources
California
$194M -$26.2M -1,152,810 -14%
BBA
5
Baker Bros. Advisors
New York
$139M +$44.6M +1,964,657 +64%
BlackRock
6
BlackRock
New York
$97M +$12.1M +535,285 +18%
State Street
7
State Street
Massachusetts
$86.8M +$20.7M +914,527 +41%
Vanguard Group
8
Vanguard Group
Pennsylvania
$77.2M +$8.62M +379,908 +16%
ACH
9
ArrowMark Colorado Holdings
Colorado
$65.4M +$34.7M +1,529,805 +183%
Wellington Management Group
10
Wellington Management Group
Massachusetts
$60M +$49.3M +2,172,946 New
EAM
11
Eagle Asset Management
Florida
$50M +$41.1M +1,811,789 New
KCM
12
Kingdon Capital Management
New York
$46M -$1.44M -63,428 -4%
Balyasny Asset Management
13
Balyasny Asset Management
Illinois
$45M +$53.5K +2,359 +0.1%
BC
14
Broadfin Capital
New York
$43.6M -$10.1M -447,102 -22%
RCMNY
15
Rubric Capital Management (New York)
New York
$41.7M -$15.6M -687,304 -31%
HCMT
16
Highland Capital Management (Texas)
Texas
$41.2M -$59.1K -2,606 -0.2%
BM
17
Bridger Management
New York
$35.3M +$29M +1,277,560 New
CTA
18
Carillon Tower Advisers
Florida
$33.7M +$28.9M +1,274,695 New
O
19
OrbiMed
New York
$31.5M +$11.1M +489,800 +75%
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
$26.9M +$10.9M +480,381 +97%
Citadel Advisors
21
Citadel Advisors
Florida
$25.7M -$15M -659,351 -41%
Alyeska Investment Group
22
Alyeska Investment Group
Illinois
$21.4M -$12.4M -544,646 -41%
Deutsche Bank
23
Deutsche Bank
Germany
$20.5M +$6.87M +302,855 +69%
Northern Trust
24
Northern Trust
Illinois
$17.3M +$1.93M +85,109 +16%
RSCM
25
Rock Springs Capital Management
Maryland
$13.1M +$5.13M +226,000 +90%
1
2 3 4 5

HRTX Hedge Fund Activity: Q1 2018 in Review

152 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q1 2018, worth a combined $2.24B — up 79% from $1.25B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new HRTX positions and 19 closed out — a net gain of 28 holders — while 54 added to existing stakes and 39 trimmed.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $49.3M. The largest seller was Carlson Capital, cutting an estimated $26.2M.

  • 152 institutional investors held Heron Therapeutics (HRTX) as of Q1 2018, up from 124 in Q4 2017.
  • Funds reported $2.24B of Heron Therapeutics stock for Q1 2018, up 79% quarter-over-quarter.
  • 47 funds opened new Heron Therapeutics positions in Q1 2018 and 19 closed out, a net change of +28 holders.
  • The largest Heron Therapeutics buyer in Q1 2018 was Wellington Management Group, an estimated $49.3M added.
  • The largest Heron Therapeutics seller in Q1 2018 was Carlson Capital, an estimated $26.2M sold.

Based on aggregated 13F filings for Q1 2018.